Glenn P. Sblendorio
2014 - Medicines
In 2014, Glenn P. Sblendorio earned a total compensation of $2.7M as Former President and Chief Financial Officer at Medicines, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $409,653 |
|---|---|
| Option Awards | $800,902 |
| Salary | $642,593 |
| Stock Awards | $806,001 |
| Other | $3,214 |
| Total | $2,662,363 |
Sblendorio received $806K in stock awards, accounting for 30% of the total pay in 2014.
Sblendorio also received $409.7K in non-equity incentive plan, $800.9K in option awards, $642.6K in salary and $3.2K in other compensation.
Rankings
In 2014, Glenn P. Sblendorio's compensation ranked 3,413th out of 13,032 executives tracked by ExecPay. In other words, Sblendorio earned more than 73.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,413 out of 13,032 | 74th |
Division Manufacturing | 1,206 out of 4,966 | 76th |
Major group Chemicals And Allied Products | 392 out of 1,686 | 77th |
Industry group Drugs | 305 out of 1,365 | 78th |
Industry Pharmaceutical Preparations | 248 out of 1,043 | 76th |
Source: SEC filing on April 25, 2016.
Sblendorio's colleagues
We found four more compensation records of executives who worked with Glenn P. Sblendorio at Medicines in 2014.